FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/09/2022
Back to search
Official data from USPTO
ODI PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ODI PHARMA
ST13
US500000079279092Class
31, 34, 41, 42
Filing
79279092
Registration
6634942
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
08/09/2022
Trademark type
Word
Nice classes
31, 34, 41, 42
Filing date
11/22/2019
Registration date
02/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/08/2022
Last transaction
02/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SE
Examiner
HUSSAIN, TASNEEM
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ODI Pharma AB
Representatives
Andrea Anderson Holland & Hart LLP
Technical classification
Nice Classes
Class 31Class 34Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 31
Malt for brewing and distilling with none of the foregoing containing any hemp or CBD; Malt for brewing and distilling and not for the production of consumable goods; cannabisunprocessedloose hemp to be used for producing hemp-based skincare products; all of the foregoing goods that contain hemp with no CBD and all of the foregoing goods that contain hemp and CBD are derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Class 34
Cigarette tobaccoraw tobaccocigarscigarettessnuffchewing tobacco with all of the foregoing containing CBD that is solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; cigarette tobaccoraw tobaccocigarscigarettessnuffchewing tobacco with none of the foregoing containing any hemp or CBD; articles for use with tobaccoashtraystobacco pipespipe racks for tobacco pipespipe cleaners for tobacco pipespocket machines for rolling cigarettestobacco filters
Class 41
Educational and training servicesclasses in the field of healthcare and pharmaceuticals; arranging and conducting of educational conferences; arrangingconducting and organisation of educational symposiums; arranging and conducting educational conferences and seminars
Class 42
industrial research in the field of pharmaceuticals; analytical laboratory services in the fields of medicine and pharmaceuticals; research laboratories in the fields of medicine and pharmaceuticals; providing information about industrial analysis and research services in the fields of medicine and pharmaceuticals; all the aforementioned excluding hemp analytical and research testing services
Publications
History of USPTO decisions and trademark events.
54 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/14/2022
FIMP
FINAL DISPOSITION PROCESSED
07/14/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2022
GPNX
NOTIFICATION PROCESSED BY IB
11/28/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/23/2021
PUBO
PUBLISHED FOR OPPOSITION
11/23/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/15/2021
ALIE
ASSIGNED TO LIE
10/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/14/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/14/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/14/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/14/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/14/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/13/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/23/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
09/20/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/20/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
09/20/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/20/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/25/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/24/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/24/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/07/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/21/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/21/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/05/2021
GNFR
FINAL REFUSAL E-MAILED
04/05/2021
CNFR
FINAL REFUSAL WRITTEN
04/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/29/2021
RFNT
REFUSAL PROCESSED BY IB
10/18/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/27/2020
RFRR
REFUSAL PROCESSED BY MPU
09/27/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2020
CNRT
NON-FINAL ACTION WRITTEN
09/08/2020
DOCK
ASSIGNED TO EXAMINER
09/01/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/20/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/20/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/20/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/20/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/20/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/20/2020
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2020
DOCK
ASSIGNED TO EXAMINER
02/27/2020
DOCK
ASSIGNED TO EXAMINER
02/26/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/20/2020
Continuous trademark protection
Get notified about every new filing that threatens ODI PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.